Intrinsiqs

Is Cytek Biosciences, Inc. overvalued?

Cytek Biosciences, Inc. (CTKB) — key valuation metrics and fundamentals.

No verdict
Price
$5.84
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$763.8M
Dividend yield
0.0%
Return on equity
-24.7%
Sector
Healthcare

See the full interactive analysis →

Fair value compares CTKB's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.